Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Solid Immuno-Oncology Oy
OY
Active
Y-tunnus 3500055-3
Tukholmankatu 8, 00290
Helsinki
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2025 · 1 year old
4 employees
Share
Finland
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Solid Immuno-Oncology Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
0M
1M
1M
1M
0M
2025
EBITDA
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2025
Income statement
EUR thousands
Item
2025
Revenue
0
Staff expenses
−207
EBITDA
−260
Depreciation & amort.
−13
EBIT
−273
Net financials
−0
Profit before tax
−273
Tax
−0
Net profit
−273
Balance sheet
EUR thousands
Item
2025
Total assets
569
Equity
527
Long-term debt
0
Short-term debt
42
Total debt
42
Financial ratios
5-year trend
EBITDA-margin
-25985200.0%
This company
15.8%
Market median
-164463391% vs market
2025
2025
Soliditetsgrad
92.6%
This company
38.2%
Market median
+142% vs market
2025
2025
Egenkapitalforrentning
-51.7%
This company
18.4%
Market median
-381% vs market
2025
2025
Nettoresultatgrad
-27276100.0%
This company
8.1%
Market median
-336742075% vs market
2025
2025
Aktivomsætning
0.00×
This company
1.12×
Market median
-100% vs market
2025
2025
Gæld/egenkapital
0.08×
This company
0.62×
Market median
+87% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
More on Solid Immuno-Oncology Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
